Metabolism of CP-195,543, a leukotriene B4 receptor antagonist, in the Long-Evans rat and Cynomolgus monkey

References

• BRAIN, S. D., CAMP, R. D. R., CUNNINGHAM, F. M., DOWD, P. M., GREAVES, M. W. and KOBZA-BLACK, A., 1984, Leukotriene B4-like material in scale of psoriatic skin lesions. British Journal of Pharmacology, 83, 313–317.
   Google Scholar
• DALVIE, D. K., KHOSLA, N. B., NAVETTA, K. A. and BRIGHTY, K. E., 1996, Metabolism and excretion of trovafloxacin, a new quinolone antibiotic, in Sprague—Dawley rats and Beagle dogs: Effect of bile-duct canulation on excretion pathways. Drug Metabolism and Disposition, 24, 1231–1240.
   PubMed Web of Science ®Google Scholar
• DALVIE, D. K., KHOSLA, N. B. and VINCENT, J., 1997, Excretion and metabolism of trovafloxacinin humans. Drug Metabolism and Disposition, 25, 423–427.
   PubMed Web of Science ®Google Scholar
• DICKINSON, R. G., KING, A. R. and VERBEECK, R. K., 1989, Elimination of diflunisal as its acyl glucuronide, phenolic glucuronide and sulphate conjugates in bile-exteriorized and intact rats. Clinical and Experimental Pharmacology and Physiology, 16, 913–924.
   PubMed Web of Science ®Google Scholar
• FAED, E. M., 1984, Properties of acyl glucuronides : implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metabolism Review, 15, 1213–1249.
   PubMed Web of Science ®Google Scholar
• FUKUDA, T., KUMURA, S., ARAKAWA, T. and KOYABASHI, K., 1990, Possible role of leukotrienes in gastritis associated with Campylobacter pylori. Journal of Clinical Gasteroenterology, 12 (suppl. 1), S131–134.
   PubMedGoogle Scholar
• GREEN, M. D., BELANGER, G., Hum, D. W., BELANGER, A. and TEPHLY, T. R., 1997, Glucuronidation of opioids, carboxylic acid-containing drugs, and hydroxylated xenobiotics catalysed by expressed monkey UDP-glucuronosyltransferase 2B9 protein. Drug Metabolism and Disposition, 25, 1389–1394.
   PubMed Web of Science ®Google Scholar
• Hai, M. J., 1995a, Carbohydrate metabolism. In M. J. Hill (ed.), Role of Gut Micrcflora in Human Toxicology and Pharmacology (London: Taylor & Francis), pp. 95–104.
   Google Scholar
• Hai, M. J., 1995b, Mechanism and consequences of enterohepatic circulation. In M. J. Hill (ed.), Role of Gut Micrcflora in Human Toxicology and Pharmacology (London: Taylor & Francis), pp. 245–259.
   Google Scholar
• Iwmu, M., &SCHER, A., NGUYEN, A. C., MCDONAGH, A. F. and BENET, L. Z., 1995, Stereoselective disposition of naproxen glucuronide in the rat. Drug Metabolism and Disposition, 23, 1099–1103.
   Google Scholar
• KLICKSTEIN, L. B., SPAPLEIGH C. and GOETZL, E. J., 1980, Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyl arthritis. Journal of Clinical Investigation, 66, 1166–1170.
   Google Scholar
• LAURITSEN, K., LAURSEN, L. S., BUKHAVE, K. and RASK-MADSEN J., 1986, Effects of topical 5-aminos alicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis. Gasteroenterology, 91, 837–844.
   Google Scholar
• O'DONNELL, J. P., KHOSLA, N. B. and DALVIE, D. K., 1998, Metabolism of droloxifene in CD-1 mouse, Fischer-344 rat and Cynomolgus monkey. Xenobiotica, 28, 153–166.
   Google Scholar
• OUELLET, D. M.-C. and POLLACK, G. M., 1995, Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats. Drug Metabolism and Disposition, 23, 478–484.
   Google Scholar
• PARKINSON, A., 1996, Biotransformation of xenobiotics. In C. D. Kaassen, M. 0. Amdur and J. Doull (eds), Casarett and Doull' s Toxicology: The Bask Science of Poisons, 5th edn (New York: McGraw-Hill), pp. 113–186.
   Google Scholar
• REITER, L. A., KocH, K., PISCOPIO, A. D., SHOWELL, H. J., ALPERT R., BIGGERS, M. S., CHAMBERS, R. J., CONKLYN, M. J., COOPER, K., CORTINA, S. R., DIBRINO, J. N., DOWNY, B. W., FARRELL, C. A., HINGORANI, G. P., MARTINELLI, G. J., RAMCHANDANI, M. and WRIGHT, K. F., 1998, Trans-3-benzy1-4-hydroxy-7-chromanylbenzoic acid derivatives as antagonists of the leukotriene B4 (LTB4) receptor. Bioorganic and Medicinal Chemistry Letters, 8, 1781–1786.
   Google Scholar
• SASABE, H., Tsuji, A. and SUGIYAIVIA, Y., 1998, Carrier-mediated mechanism for the biliary excretion of the quinolone antibiotic grepafloxacin and its glucuronide in rats. Journal of Pharmacology and Experimental Therapeutics, 284, 1033–1039.
   PubMed Web of Science ®Google Scholar
• SCHELINE, R. R., 1973, Metabolism of foreign compounds by gastrointestinal microorganisms. Pharmacological Reviews, 25,451–523.
   PubMed Web of Science ®Google Scholar
• SCHNEIDER, R. P., DAVENPORT, C. J., HoFFiviAsTER, K. A. and INSKEEP, P. B., 1998a, Bioavailability, multiple-dose pharmacokinetics, and biotransformation of the aldose reductase inhibitor zopolrestat in dogs. Drug Metabolism and Disposition, 26, 1160–1166.
   PubMedGoogle Scholar
• SCHNEIDER, R. P., FOUDA, H. G. and INSKEEP, P. B., 1998b, Tissue distribution and biotransformation of zopolrestat, an aldose reductase inhibitor, in rats. Drug Metabolism and Disposition, 26, 1149–1159.
   PubMedGoogle Scholar
• SErrz, S. and BOELSTERLI, U. A., 1998, Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats. Gastroenterology, 115, 1476–1482.
   PubMedGoogle Scholar
• SHARON, P. and STENSON, W. F., 1984, Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gasteroenterology, 86, 453–460.
   PubMed Web of Science ®Google Scholar
• SHAW, R. J., FITZHARRIS, P., CROMWELL, O., WARDLOW, A. J. and KAY, A. B., 1985, Allergen induced release of sulfidopeptide (SRS-A) and LTB, in allergic rhinitis. Allergy, 40, 1–6.
   PubMed Web of Science ®Google Scholar
• SHINDO, K., MATSUMOTO, Y., HIRAI, Y., SUMITOMO, M., AIVIANO, T. and MIYAKAWA, K., 1990, Measurement of leukotriene B4 in arterial blood of asthmatic patients during wheezing attacks. Journal of International Medicine, 228, 91–96.
   PubMedGoogle Scholar
• SHOWELL, H. J., CONKLYN, M. J., ALPERT, R., HINGORANI, G. P., WRIGHT, K. F., Smut', M. A., SIAM, E., SALTER, E. D., SCAMPOLI, D. N., MELTZER, S., REITER, L. A., Kocx, K., PISCOPIO, A. D., CORTINA, S. R., LOPEZ-ANAYA, A., PETTIPHER, E. R., Mrucr, A. J. and GRIFFITHS, R. J., 1998, The preclinical pharmacological profile of the potent and selective leukotriene 4 antagonist CP-195543. Journal of Pharmacology and Experimental Therapeutics, 285, 946–954.
   Google Scholar
• SINCLAIR, K. A. and CALDWELL, J., 1981, The pH-dependent intramolecular rearrangement of glucuronic acid conjugates of xenobiotics. Biochemical Society Transactions, 9, 215.
   Google Scholar
• SPAHN -LANGGUTH, H. and BT, L. Z., 1992, Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? Drug Metabolism Reviews, 24, 5–47.
   Google Scholar
• TAKENAKA O., HORIE, T., Suzum, H. and SUGIYAIVIA, Y., 1997, Carrier-mediated active transport of the glucuronide and sulphate of 6-hydroxy-5,7-dimethy1-2-methylamino-4-(3-pyridylmethypbenzo-thiazole (E3040) into rat liver: quantitative comparison of permeability in isolated hepatocytes, perfused liver and liver in vivo. Journal of Pharmacology and Experimental Therapeutics, 280, 948–958.
   Google Scholar
• TSUCHP/A, T. and LEVY, G., 1972, Biotransformation of salicylic acid to its acyl and phenolic glucuronides in man. Journal of Pharmaceutical Sciences, 61, 800–801.
   PubMedGoogle Scholar
• WARDLAW, A. J., HAY, H., CROMWELL, 0., COLLINS, J. V. and KAY, A. B., 1989, Leukotrienes LTC4 and LTB4 in bronchoalveolar lavage in asthma and other respiratory diseases. Journal of Allergy and Clinical Immunology, 84, 19–26.
   Google Scholar